Essential signaling pathways involved in tumor cell proliferation and survival, such as epithelial growth factor receptor (EGFR) /Janus kinase 2 (JAK2)/ Signal transducer and activator of transcription 3 (STAT3) and mTOR pathways, have been reported to be propofol’s targets [13, 18]. This evidence concerns the gene EGFR and neoplasm.